1200-1300
Online
Speakers: Dr Hussein Al-Mossawi (Global Clinical Head for Anifrolumab, Late Respiratory and Immunology)
Company: AstraZeneca
Building on decades of research, AstraZeneca is starting to unravel complex inflammatory cell signalling pathways and uncover key drivers that cause an imbalance in immune-mediated diseases.
This seminar is part of the University of Oxford Medical Sciences Division’s, Industry Insights Seminar Series.